person · Reporting owner
Miller Brian Christopher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SkinHealth Systems Inc.SKIN · Entity 6863 | Director | June 16, 2025 | June 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SkinHealth Systems Inc.
Report date June 16, 2025 · Filed June 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 243,035 |
Reported balance
After 2025-06-16 transaction · row 1
1 source rowRow 1 · 2025-06-16 · Grant · Acquired 73,051 · Balance 243,035 F1: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2025 Filed Jun 18, 2025 20:31 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 73,051 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-032139 · wk-form4_1750278699.xml · nonDerivative · entry 1 Miller Brian Christopher · CIK 0001857685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,035 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2026 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 20:46 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 78,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-031601 · wk-form4_1720644396.xml · nonDerivative · entry 1 Miller Brian Christopher · CIK 0001857685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,984 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2025 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 23:16 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | PurchaseClass A Common Stock | 60,000 | $5.81 | $348,600.00 |
DisclosureSEC source: 0001628280-23-030152 · wk-form4_1692659773.xml · nonDerivative · entry 1 Miller Brian Christopher · CIK 0001857685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,450 Read SEC document |
| July 07, 2023 Filed Jul 7, 2023 20:05 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock | 3,207,261 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-017267 · doc4.xml · nonDerivative · entry 1 LCP Edge Holdco LLC · CIK 0001860184 · 10% owner Linden Capital III LLC · CIK 0001859894 · 10% owner Linden Manager III LP · CIK 0001859892 · 10% owner LINDEN CAPITAL PARTNERS III LP · CIK 0001627844 · 10% owner LINDEN CAPITAL PARTNERS III-A LP · CIK 0001627845 · 10% owner DAVIS ANTHONY B. · CIK 0001563784 · 10% owner Miller Brian Christopher · CIK 0001857685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 33,360,741 F1 · kind: The reported securities were distributed by LCP Edge Holdco, LLC to certain of its unitholders for no consideration. F2 · ownership.nature: The reported securities are directly held by LCP Edge Holdco, LLC. Linden Capital III LLC is the general partner of Linden Manager III LP, which in turn is the general partner of both Linden Capital Partners III LP and Linden Capital Partners III-A LP, which are the controlling stockholders of LCP Edge Holdco, LLC. As the members of a limited partner committee of Linden Capital III LLC that has the power to vote or dispose of the shares directly held by LCP Edge Holdco, LLC, Brian Miller and Anthony Davis may be deemed to have shared voting and investment power over such shares. Each of the reporting persons disclaim beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:19 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 16,357 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-022513 · wk-form4_1686950340.xml · nonDerivative · entry 1 Miller Brian Christopher · CIK 0001857685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,450 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2024 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| June 28, 2022 Filed Jul 1, 2022 00:06 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 9,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001818093-22-000121 · wf-form4_165663398307641.xml · nonDerivative · entry 1 Miller Brian Christopher · CIK 0001857685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,093 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · acquired: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the earlier of the one-year anniversary of the grant and the date of the 2023 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:26 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock | 5,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001818093-21-000078 · wf-form4_163166916888876.xml · nonDerivative · entry 1 Miller Brian Christopher · CIK 0001857685 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,160 F1 · kind: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the date of the 2022 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. F1 · price: Represents a grant of restricted stock units ("RSUs"). The RSUs vest on the date of the 2022 Annual Meeting of Stockholders of the Company, contingent upon the reporting person's continued service as a member of the Company's board of directors through such time. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 22:05 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock, par value $0.0001 per share | 59,906 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-034446 · doc4.xml · nonDerivative · entry 1 LCP Edge Holdco LLC · CIK 0001860184 · 10% owner Linden Capital III LLC · CIK 0001859894 · 10% owner Linden Manager III LP · CIK 0001859892 · 10% owner LINDEN CAPITAL PARTNERS III LP · CIK 0001627844 · 10% owner LINDEN CAPITAL PARTNERS III-A LP · CIK 0001627845 · 10% owner DAVIS ANTHONY B. · CIK 0001563784 · 10% owner Miller Brian Christopher · CIK 0001857685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 36,568,002 F1 · kind: The reported acquisition reflects working capital adjustment shares issued pursuant to the Agreement and Plan of Merger by and among Vesper Healthcare Acquisition Corp., Hydrate Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, Hydrate Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer, LCP Edge Intermediate, Inc., a Delaware corporation and indirect parent of Edge Systems LLC d/b/a The HydraFacial Company and LCP Edge Holdco LLC dated December 8, 2020. F1 · price: The reported acquisition reflects working capital adjustment shares issued pursuant to the Agreement and Plan of Merger by and among Vesper Healthcare Acquisition Corp., Hydrate Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, Hydrate Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer, LCP Edge Intermediate, Inc., a Delaware corporation and indirect parent of Edge Systems LLC d/b/a The HydraFacial Company and LCP Edge Holdco LLC dated December 8, 2020. F2 · ownership.direct: This Form 4 is being filed jointly by (i) LCP Edge Holdco LLC, (ii) Linden Capital III LLC, (iii) Linden Manager III LP, (iv) Linden Capital Partners III LP, (v) Linden Capital Partners III-A LP, (vi) Anthony Davis and (vii) Brian Miller in respect of shares that are held directly by LCP Edge Holdco. F3 · ownership.nature: The shares directly held by LCP Edge Holdco LLC may be deemed to be beneficially owned by Linden Capital III LLC, the general partner of Linden Manager III LP. Linden Manager III LP is the general partner of both Linden Capital Partners III LP and Linden Capital Partners III-A LP, which are the controlling stockholders of LCP Edge Holdco LLC. As the members of a limited partner committee of Linden Capital III LLC that has the power to vote or dispose of the shares directly held by LCP Edge Holdco LLC, Brian Miller and Anthony Davis may be deemed to have shared voting and investment power over such shares. Each of Linden Capital III LLC, Linden Manager III LP, Linden Capital Partners III LP, Linden Capital Partners III-A LP, Mr. Miller and Mr. Davis hereby disclaim any beneficial ownership of any shares held by LCP Edge Holdco LLC except to the extent of any pecuniary interest therein. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 21:05 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | GrantClass A Common Stock, par value $0.0001 per share | 6,340,429 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-028843 · doc4.xml · nonDerivative · entry 1 LCP Edge Holdco LLC · CIK 0001860184 · 10% owner Linden Capital III LLC · CIK 0001859894 · 10% owner Linden Manager III LP · CIK 0001859892 · 10% owner LINDEN CAPITAL PARTNERS III LP · CIK 0001627844 · 10% owner LINDEN CAPITAL PARTNERS III-A LP · CIK 0001627845 · 10% owner DAVIS ANTHONY B. · CIK 0001563784 · 10% owner Miller Brian Christopher · CIK 0001857685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 36,508,096 F1 · kind: The reported acquisition reflects earnout shares issued pursuant to the Agreement and Plan of Merger by and among Vesper Healthcare Acquisition Corp., Hydrate Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, Hydrate Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer, LCP Edge Intermediate, Inc., a Delaware corporation and indirect parent of Edge Systems LLC d/b/a The HydraFacial Company and LCP Edge Holdco LLC dated December 8, 2020. F2 · ownership.direct: This Form 4 is being filed jointly by (i) LCP Edge Holdco LLC, (ii) Linden Capital III LLC, (iii) Linden Manager III LP, (iv) Linden Capital Partners III LP, (v) Linden Capital Partners III-A LP, (vi) Anthony Davis and (vii) Brian Miller in respect of shares that are held directly by LCP Edge Holdco. F3 · ownership.nature: The shares directly held by LCP Edge Holdco LLC may be deemed to be beneficially owned by Linden Capital III LLC, the general partner of Linden Manager III LP. Linden Manager III LP is the general partner of both Linden Capital Partners III LP and Linden Capital Partners III-A LP, which are the controlling stockholders of LCP Edge Holdco LLC. As the members of a limited partner committee of Linden Capital III LLC that has the power to vote or dispose of the shares directly held by LCP Edge Holdco LLC, Brian Miller and Anthony Davis may be deemed to have shared voting and investment power over such shares. Each of Linden Capital III LLC, Linden Manager III LP, Linden Capital Partners III LP, Linden Capital Partners III-A LP, Mr. Miller and Mr. Davis hereby disclaim any beneficial ownership of any shares held by LCP Edge Holdco LLC except to the extent of any pecuniary interest therein. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:34 UTC | SkinHealth Systems Inc. SKIN · Entity 6863 | OtherClass A Common Stock, par value $0.0001 per share | 3,188,671 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-020352 · doc4.xml · nonDerivative · entry 1 LCP Edge Holdco LLC · CIK 0001860184 · 10% owner Linden Capital III LLC · CIK 0001859894 · 10% owner Linden Manager III LP · CIK 0001859892 · 10% owner LINDEN CAPITAL PARTNERS III LP · CIK 0001627844 · 10% owner LINDEN CAPITAL PARTNERS III-A LP · CIK 0001627845 · 10% owner DAVIS ANTHONY B. · CIK 0001563784 · 10% owner Miller Brian Christopher · CIK 0001857685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 30,167,667 F1 · kind: The transactions reported are the result of distributions for no consideration made by LCP Edge Holdco LLC to certain of its unitholders in redemption of their interests in LCP Edge Holdco LLC as described in the statement on Schedule 13D jointly filed by the reporting persons with the U.S. Securities and Exchange Commission on May 14, 2021. The shares of Class A Common Stock, par value $0.0001 per share (the "shares") distributed remain subject to at least the same lock-up restrictions as those agreed to by LCP Edge Holdco LLC in connection with the Beauty Health Company's business combination. F2 · ownership.direct: This Form 4 is being filed jointly by (i) LCP Edge Holdco LLC, (ii) Linden Capital III LLC, (iii) Linden Manager III LP, (iv) Linden Capital Partners III LP, (v) Linden Capital Partners III-A LP, (vi) Anthony Davis and (vii) Brian Miller in respect of shares that are held directly by LCP Edge Holdco. F3 · ownership.nature: The shares directly held by LCP Edge Holdco LLC may be deemed to be beneficially owned by Linden Capital III LLC, the general partner of Linden Manager III LP. Linden Manager III LP is the general partner of both Linden Capital Partners III LP and Linden Capital Partners III-A LP, which are the controlling stockholders of LCP Edge Holdco LLC. As the members of a limited partner committee of Linden Capital III LLC that has the power to vote or dispose of the shares directly held by LCP Edge Holdco LLC, Brian Miller and Anthony Davis may be deemed to have shared voting and investment power over such shares. Each of Linden Capital III LLC, Linden Manager III LP, Linden Capital Partners III LP, Linden Capital Partners III-A LP, Mr. Miller and Mr. Davis hereby disclaim any beneficial ownership of any shares held by LCP Edge Holdco LLC except to the extent of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.